+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Medical Bionics Market by Type, and Method of Fixation - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4612681
  • Report
  • April 2017
  • Region: Global
  • 180 pages
  • Allied Analytics LLP
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now
Bionics is the science of constructing artificial systems, which imitates the function of original organ. These artificial systems are used to replace a non-functional organ, which could be lost due to trauma, disease, and congenital defect.

The global medical bionics market generated $15,348 million in 2016, and is projected to reach $29,160 million by 2023, registering a CAGR of 9.6% during the study period. The medical bionics market is expected to witness significant growth during the forecast period, owing to increase in demand for organ transplant, dearth of organ donor, and rise in number of road accidents or work-related injuries leading to amputations. In addition, increase in pool of geriatric population, which are prone to organ failure and availability of technologically advanced products, such as total artificial heart, promotes the market growth. However, high cost of devices & treatments, dearth of skilled professionals, and unfavorable reimbursement policies are expected to restrain the market growth.

The global medical bionics market is segmented on the basis of product, method of fixation, and geography. Based on product type, it is classified into vision bionics, ear bionics, orthopedic bionics, cardiac bionics, and neural bionic. On the basis of method of fixation, it is bifurcated into implantable bionics and fixation bionics. Geographically, it is analyzed into North America, Europe, Asia-Pacific, and LAMEA.

The global medical bionics market is highly competitive and is lucrative in nature. The key market players have adopted various developmental strategies, such as product launch & approval, strategic acquisitions, and mergers to strengthen their market position.

KEY BENEFITS FOR STAKEHOLDERS

This report provides an extensive analysis of the current & emerging market trends and dynamics in the global medical bionics market.
Comprehensive analysis of geographical regions is provided to determine the prevailing opportunities in the global market.
This study provides the competitive landscape of the global market to predict the competitive environment globally.
This report entails the detailed quantitative analysis of the current market and estimations from 2017 to 2023 to identify the prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.

KEY MARKET SEGMENTS

By Product

Vision Bionics/Bionic Eye
Ear Bionics
Cochlear Implant
Bone Anchored Hearing System
Auditory Brainstem Implant
Orthopedic Bionics
Upper Limb
Lower Limb
Bionic Knee
Bionic Feet
Exoskeleton
Electrical Bone Growth Stimulator
Invasive Bone Growth Stimulator
Non-Invasive Bone Growth Stimulator
Cardiac Bionics
Pacemaker
Total Artificial Heart
Ventricular Assist Device
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)
Artificial Heart Valve
Mechanical Heart Valve
Tissue Heart Valve
Neural /Brain Bionics
Internal Neurostimulator
Deep Brain Stimulator (DBS)
Sacral Nerve Stimulator (SNS)
Vagus Nerve Stimulator (VNS)
Spinal Cord Stimulator (SCS)
Other Neurostimulator
External Neurostimulator (Transcutaneous Electrical Nerve Stimulation (TENS))

By Method of Fixation

Implantable Bionics
External Bionics

By Region

North America
U.S.
Canada
Mexico
Europe
France
Germany
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

The key players in the global medical bionics market include

ABBOTT LABORATORIES
Boston Scientific Corporation
Cochlear Ltd.
LivaNova PLC.
Medtronic plc.
Orthofix Holdings, Inc.
Össur Corporate
Retina Implant AG
Sonova
SECOND SIGHT
SynCardia Systems, LLC
William Demant Holding A/S
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Market share analysis, 2016
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Rise in number of patients suffering from chronic diseases
3.3.1.2. Increasing pool of geriatric population
3.3.1.3. Technological advancements
3.3.1.4. Increasing government focus on funding R&D initiatives
3.3.2. Restraints
3.3.2.1. High cost of treatment
3.3.2.2. Stringent approval process
3.3.3. Opportunities
3.3.3.1. Lucrative opportunities in emerging economies
3.3.4. Impact Analysis
3.4. GOVERNMENT REGULATIONS
3.5. CLINICAL TRIALS

CHAPTER 4 GLOBAL MEDICAL BIONICS MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. VISION BIONICS/ BIONICS EYE
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. EAR BIONICS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.3.1. Cochlear implants
4.3.3.2. Market size and forecast
4.3.3.3. Bone Anchored Hearing Systems (BAHS)
4.3.3.4. Market size and forecast
4.3.3.5. Auditory brainstem implants
4.3.3.6. Market size and forecast
4.4. ORTHOPEDIC BIONICS
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.4.3.1. Upper limb
4.4.3.2. Market size and forecast
4.4.3.3. Lower limb
4.4.3.4. Market size and forecast
4.4.3.4.1. Bionic knee
4.4.3.4.2. Market size and forecast
4.4.3.4.3. Bionic feet
4.4.3.4.4. Market size and forecast
4.4.3.5. Exoskeleton
4.4.3.6. Market size and forecast
4.4.3.7. Electrical bone growth stimulators
4.4.3.8. Market size and forecast
4.4.3.8.1. Invasive bone growth stimulators
4.4.3.8.2. Market size and forecast
4.4.3.8.3. Non-invasive bone growth stimulators
4.4.3.8.4. Market size and forecast
4.5. CARDIAC BIONICS
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Pacemaker
4.5.4.1. Implantable pacemaker
4.5.4.2. External pacemaker
4.5.5. Market size and forecast
4.5.6. Total artificial heart
4.5.7. Market size and forecast
4.5.8. Ventricular assist device (VADs)
4.5.9. Market size and forecast
4.5.9.1. Left Ventricular Assist Device (LVAD)
4.5.9.2. Market size and forecast
4.5.9.3. Right Ventricular Assist Device (RVAD)
4.5.9.4. Market size and forecast
4.5.9.5. Biventricular Assist Device (BIVAD)
4.5.9.6. Market size and forecast
4.5.10. Artificial Heart Valves
4.5.11. Market size and forecast
4.5.11.1. Mechanical Heart Valves
4.5.11.2. Market size and forecast
4.5.11.3. Tissue Heart Valves
4.5.11.4. Market size and forecast
4.6. NEURAL/BRAIN BIONICS
4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Internal Neurostimulators
4.6.5. Market size and forecast
4.6.5.1. Deep Brain Stimulators (DBS)
4.6.5.2. Market size and forecast
4.6.5.3. Sacral Nerve Stimulators (SNS)
4.6.5.4. Market size and forecast
4.6.5.5. Vagus Nerve Stimulators (VNS)
4.6.5.6. Market size and forecast
4.6.5.7. Spinal Cord Stimulators (SCS)
4.6.5.8. Market size and forecast
4.6.5.9. Other Neurostimulators
4.6.5.10. Market size and forecast
4.6.6. External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))
4.6.7. Market size and forecast

CHAPTER 5 GLOBAL MEDICAL BIONICS MARKET, BY METHOD OF FIXATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. IMPLANTABLE BIONICS
5.2.1. Market size and forecast
5.3. EXTERNAL BIONICS
5.3.1. Market size and forecast

CHAPTER 6 GLOBAL MEDICAL BIONICS MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S. market size and forecast
6.2.5. Canada market size and forecast
6.2.6. Mexico market size and forecast
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany market size and forecast
6.3.5. France market size and forecast
6.3.6. UK market size and forecast
6.3.7. Italy market size and forecast
6.3.8. Spain market size and forecast
6.3.9. Rest of Europe market size and forecast
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan market size and forecast
6.4.5. China market size and forecast
6.4.6. India market size and forecast
6.4.7. Australia market size and forecast
6.4.8. Malaysia market size and forecast
6.4.9. Rest of Asia-Pacific market size and forecast
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil market size and forecast
6.5.5. South Africa market size and forecast
6.5.6. Saudi Arabia market size and forecast
6.5.7. Rest of LAMEA market size and forecast

CHAPTER 7 COMPANY PROFILES
7.1. ABOTT LABORATORIES
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Business performance
7.1.5. Key strategic moves and developments
7.1.6. Strategy share (%)
7.2. BOSTON SCIENTIFIC CORPORATION
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Business performance
7.2.5. Key strategic moves and developments
7.2.6. Strategy share (%)
7.3. COCHLEAR LTD.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Business performance
7.3.5. Key strategic moves and developments
7.3.6. Strategy share (%)
7.4. LIVANOVA PLC
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance
7.4.5. Key strategic moves and developments
7.4.6. Strategy share (%)
7.5. MEDTRONIC PLC
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Business performance
7.5.5. Key strategic moves and developments
7.5.6. Strategy share (%)
7.6. ORTHOFIX HOLDINGS, INC.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance
7.6.5. Key strategic moves and developments
7.6.6. Strategy share (%)
7.7. OSSUR
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Business performance
7.7.5. Key strategic moves and developments
7.7.6. Strategy share (%)
7.8. RETINA IMPLANT AG
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Business performance
7.8.5. Key strategic moves and developments
7.8.6. Strategy share (%)
7.9. SONOVA
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Business performance
7.9.5. Key strategic moves and developments
7.9.6. Strategy share (%)
7.10. SECOND SIGHT MEDICAL PRODUCTS, INC.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Business performance
7.10.5. Key strategic moves and developments
7.10.6. Strategy share (%)
7.11. SYNCARDIA SYSTEMS, LLC
7.11.1. Company overview
7.11.2. Company snapshot
7.11.3. Operating business segments
7.11.4. Business performance
7.11.5. Key strategic moves and developments
7.11.6. Strategy share (%)
7.12. WILLIAM DEMANT HOLDING A/S
7.12.1. Company overview
7.12.2. Company snapshot
7.12.3. Operating business segments
7.12.4. Business performance
7.12.5. Key strategic moves and developments
7.12.6. Strategy share (%)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Medical Bionics Market Report, forecasts that the global market was valued at $15,348 million in 2016, and is expected to garner $29,160 million by 2023, registering a CAGR of 9.6% during the forecast period 2017 - 2023. Cardiac bionics segment held more than one-third share of the total market in 2016.

Bionics are the implantable devices, which imitates the function of a tural organ. Advent of technologically advanced systems such as cochlear implants and rise in incidence of chronic disease majorly drive the market growth. In addition, rise in geriatric population and increased focus of government funding on R&D initiatives are anticipated to further drive the demand for medical bionics globally. However, high cost of the device and stringent regulatory approval procedures restrict the market growth.

Cardiac bionics are expected to domite the market throughout the alysis period, owing to the increase in the incidence of cardiac disorders, such as heart failure and structural heart defects. On the other hand, bionic eye segment is expected to grow at the highest CAGR of 13.9% during the forecast period.

Key findings of Medical Bionics Market:

Bionic eye segment is projected to grow at a CAGR of 13.9% during the forecast period.
Implantable bionics accounted for more than four-fifths share of the global medical bionics market.
Exoskeleton segment is expected to register the highest CAGR of 21.0% during the alysis period owing to the increasing number of amputees.
France and Germany jointly contributed for nearly one-fourth of the European medical bionics market in 2015.
Japan is the major shareholder, accounting for almost one-third of the Asia-Pacific medical bionics market in 2015.

Asia-Pacific is projected to grow at the highest CAGR of 11.4% during the forecast period owing to improvement in healthcare infrastructures and rise in expenditures in emerging markets (such as India and Chi) to overcome the unmet medical needs. Technological advancements to develop cost-effective devices in these tions offer a lucrative opportunity for market growth.

The major companies profiled in the report include Abbott, Boston Scientific Corporation, Cochlear Ltd., LivaNova PLC, Medtronic plc, Orthofix Holdings, Inc., ssur Corporate, Reti Implant AG, Sonova, SECOND SIGHT, SynCardia Systems, LLC, and William Demant Holding A/S.
Note: Product cover images may vary from those shown
5 of 4

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll